Is tocilizumab a potential therapeutic option for refractory unicentric Castleman disease?
Hematol Oncol. 2018 Feb;36(1):320-323. doi: 10.1002/hon.2420. Epub 2017 Apr 11.
Hematol Oncol. 2018.
PMID: 28401573